Pregnant Women

Women who used oral fluconazole — a common treatment for vulvovaginal candidiasis — during the first trimester of pregnancy were more likely to give birth to an infant with musculoskeletal malformations, but not oral clefts or conotruncal malformations, which were previously linked to the medication, according to a study published in BMJ.

A recent model estimated that more than 16,000 pregnant women delivering at hospitals in the United States in 2020 will have COVID-19. The model also predicted there will be 52 COVID-19-related maternal mortalities, according to research published in the American College of Obstetrics & Gynecology MFM.

Women with psoriasis may have an increased risk for adverse maternal and pregnancy outcomes; however, fertility does not seem to be negatively affected, according to a study in Journal of the American Academy of Dermatology.

The U.S. Preventive Services Task Force recommended against screening for bacterial vaginosis in asymptomatic pregnant women who are not at increased risk for preterm delivery. The task force also said there is insufficient evidence to assess the balance of benefits and harms of screening for bacterial vaginosis in asymptomatic pregnant women who are at increased risk for preterm delivery.

WHO, CDC and the American College of Obstetricians and Gynecologists have all issued recommendations to health care professionals for the treatment of pregnant women during the COVID-19 pandemic.

Pregnant women who had maternal vitamin 25-hydroxyvitamin D levels less than 100 nmol/L were more likely to have children with ADHD, according to a population-based case-control study published in the Journal of the American Academy of Child & Adolescent Psychiatry.

Pregnancies exposed to oral or topical terbinafine had no increased risk for major malformations or spontaneous abortion compared with unexposed pregnancies, according to a study.

High-risk pregnant women who were nonadherent to prescribed aspirin experienced greater risk for poor clinical outcomes compared with women who were adherent, according to research published in Hypertension.

Women with anxiety, depression and trauma were more likely to use cannabis during pregnancy, according to research published in JAMA Network Open.

Children may be more likely to develop overweight or obesity if their mothers are exposed to high levels of paraben while pregnant, according to findings published in Nature Communications.